CINECA IRIS Institutional Research Information System

MOROTTI, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.875
EU - Europa 3.566
AS - Asia 2.484
AF - Africa 30
SA - Sud America 17
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 7
Totale 12.995
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.804
CN - Cina 1.172
IT - Italia 919
SG - Singapore 661
IE - Irlanda 521
FR - Francia 360
SE - Svezia 342
FI - Finlandia 321
DE - Germania 310
UA - Ucraina 234
KR - Corea 186
AT - Austria 159
VN - Vietnam 142
PL - Polonia 113
DK - Danimarca 100
JP - Giappone 84
GB - Regno Unito 81
ID - Indonesia 72
CA - Canada 45
IN - India 40
HK - Hong Kong 33
LB - Libano 29
BE - Belgio 21
MX - Messico 19
NL - Olanda 17
TW - Taiwan 17
AU - Australia 14
BR - Brasile 12
IR - Iran 12
SN - Senegal 12
ES - Italia 9
PT - Portogallo 9
RU - Federazione Russa 9
EG - Egitto 8
GR - Grecia 8
RO - Romania 8
TR - Turchia 8
PR - Porto Rico 6
CZ - Repubblica Ceca 5
EU - Europa 5
MO - Macao, regione amministrativa speciale della Cina 5
NO - Norvegia 5
ZA - Sudafrica 5
CH - Svizzera 4
HU - Ungheria 4
MY - Malesia 4
BD - Bangladesh 3
BG - Bulgaria 3
CL - Cile 3
IL - Israele 3
IQ - Iraq 3
TH - Thailandia 3
AP - ???statistics.table.value.countryCode.AP??? 2
BT - Bhutan 2
DZ - Algeria 2
LT - Lituania 2
NZ - Nuova Zelanda 2
RS - Serbia 2
TN - Tunisia 2
AR - Argentina 1
AZ - Azerbaigian 1
LK - Sri Lanka 1
MA - Marocco 1
NI - Nicaragua 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
UZ - Uzbekistan 1
Totale 12.995
Salva come PNG Salva come JPEG
Città #
Beijing 689
Chandler 671
Fairfield 573
Singapore 553
Dublin 521
Santa Clara 481
Ashburn 360
Ann Arbor 355
Houston 355
Torino 311
Villeurbanne 302
Woodbridge 287
Wilmington 276
Seattle 228
Dearborn 217
Cambridge 178
Nyköping 168
Jacksonville 165
Vienna 158
Columbus 154
Princeton 142
Pisa 134
Medford 118
Warsaw 108
Turin 95
Boston 94
Dong Ket 88
Jakarta 71
Fremont 63
New York 60
Düsseldorf 44
San Mateo 42
Nanjing 40
Guangzhou 39
Munich 31
San Diego 31
Redwood City 30
Hangzhou 28
Hefei 28
Milan 27
Toronto 26
Phoenix 25
Shanghai 23
Boardman 22
Helsinki 22
Norwalk 21
Washington 18
Hebei 17
Hong Kong 17
Brussels 16
Kunming 16
Silver Spring 16
Taipei 15
Chengdu 14
Seoul 14
Changsha 13
Upper Marlboro 13
Falls Church 12
Gravina In Puglia 12
Los Angeles 12
Nanchang 12
San Jose 12
Tokyo 12
Fuzhou 11
Rome 11
Piemonte 10
Pune 10
Wuhan 10
Duncan 9
Verona 9
Vestignè 9
Xian 9
Zhengzhou 9
Buffalo 8
Jinan 8
Nuremberg 8
Ottawa 8
Sesto San Giovanni 8
Shenyang 8
La Jolla 7
Malappuram 7
Mountain View 7
Napoli 7
Paris 7
Taiyuan 7
Berlin 6
Chongqing 6
Des Moines 6
Marburg 6
Bologna 5
Central District 5
Edinburgh 5
Glasgow 5
Hyderabad 5
Lappeenranta 5
Mexico City 5
Nagareyama 5
Nanning 5
North Charleston 5
Omaha 5
Totale 8.961
Salva come PNG Salva come JPEG
Nome #
Morgana acts as an oncosuppressor in chronic myeloid leukemia. 448
P53 vs NF-κB: the role of nuclear factor-kappa B in the regulation of p53 activity and vice versa 380
Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones 336
Morgana is a new oncosuppressor in CML 238
Non-Oncogene Addiction to BRD in CLL: from JQ1 Response to Resistence 213
Hepatocyte Growth Factor-mediated satellite cells niche perturbation promotes development of distinct sarcoma subtypes 208
Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma 195
BCR-ABL inactivates cytosolic PTEN through casein kinase II mediated tail phosphorylation 192
New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemia 183
BCR-ABL Promotes PTEN Downregulation in Chronic Myeloid Leukemia. 181
The BCR-ABL/NF-κB signal transduction network: a long lasting relationship in Philadelphia positive Leukemias 180
Variable but consistent pattern of Meningioma 1 gene (MN1) expression in different genetic subsets of acute myelogenous leukaemia and its potential use as a marker for minimal residual disease detection 159
When collateral vessels matter: asymptomatic Leriche syndrome 155
Small bowel cancer diagnosis: role of nuclear magnetic resonance 151
The targetable role of herpes virus-associated ubiquitin-specific protease (HAUSP) in p190 BCR-ABL leukemia 143
The role of the tumor suppressor PTEN in Chronic Myeloid Leukemia pathogenesis 142
Targeting few to help hundreds: JAK, MAPK and ROCK pathways as druggable targets in atypical chronic myeloid leukemia 141
DOK2 inhibits EGFR-mutated lung adenocarcinoma 137
Milestones and Monitoring 136
The IKK/NF-κB signaling pathway requires Morgana to drive breast cancer metastasis 136
Phenotypical heterogeneity of acute myeloid leukemia in the elderly: a clue for a personalized therapy? 133
A very sensitive and rapid method for BCR-ABL T315Imutation detection by peptide nucleic acid directed PCR clamping 132
Mechanisms of p53 Functional De-Regulation: Role of the IκB-α/p53 Complex 130
INHIBITION OF USP7 INDUCES SELECTIVE CANCER CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA THROUGH PTEN AND INDEPENDENTLY FROM P53 STATUS 128
Gastropancreatic fistula in a patient with chronic pancreatitis and IPMN 127
NEW ALTERNATIVE PROTEIN Bcr/Abl-OOF SHOWS ONCOGENIC ACTIVITY BY ACTIVATION OF RAC AND COOPERATION WITH Bcr/Abl IN CHRONIC MYELOID LEUKEMIA. 125
A new non canonical role of IkB-alpha in chronic myleoid leukemia pathogenesis 124
Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias 123
Bortezomib-mediated proteasome inhibition as a potential strategy for the treatment of rhabdomyosarcoma 122
ALTERNATIVE SPLICING VARIANT COULD BE RESPONSIBLE OF MORGANA UNDER-EXPRESSION IN ACML 121
Rare Bone Marrow Biopsy Complication: A Challenging Case of Sacroiliitis and Staphilococcus Aureus Sepsis 121
Tumor suppressors in chronic lymphocytic leukemia: From lost partners to active targets 120
Inhibition of bromodomain and extra-terminal proteins increases sensitivity to venetoclax in chronic lymphocytic leukaemia 118
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways 117
Tumor suppressors revival in CLL 116
Association between high on-aspirin platelet reactivity and reduced superoxide dismutase activity in patients affected by type 2 diabetes mellitus or primary hypercholesterolemia 116
IκBα targeting promotes oxidative stress-dependent cell death 116
The non-genomic loss of function of tumor suppressors: an essential role in the pathogenesis of chronic myeloid leukemia chronic phase 115
RNAi technology and lentiviral delivery as a powerful tool to suppress Tpr-Met-mediated tumorigenesis 114
Emergency management of major bleeding in a case of maxillofacial trauma and anticoagulation: utility of prothrombin complex concentrates in the shock room 111
Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBα mediated p53 nuclear exclusion 105
ROCK AS THERAPEUTICAL TARGET FOR MORGANA LOW CML 104
Inhibition OF USP7 Induces Selective Cancer Cell Death in Chronic Lymphocytic Leukemia 102
Targeting the extracellular HSP90 co-chaperone Morgana inhibits cancer cell migration and promotes anti-cancer immunity 99
Recommendations for the Management of CML in the Era of Second-Generation TKIs 98
Modeling myeloproliferative neoplasms: From mutations to mouse models and back again 97
A new oncogenic role of BCR-ABL/OOF in chronic myeloid leukemia pathogenesis 96
FOXO3 TRANSCRIPTION FACTOR IS DELOCALIZED AND INACTIVATED IN CML PATIENTS BY BCR-ABL ONCOGENIC SIGNALLING 96
Strategies For Targeting Chronic Myeloid Leukaemia Stem Cells 94
BCR-ABL disrupts PTEN nuclear-cytoplasmic shuttling through phosphorylation-dependent activation of HAUSP 92
The Non Receptor Transmembrane Tyrosine Kinase STYK1 Represents a Novel Lymphocyte Marker, Whose Expression Is Deregulated in Leukemia, and a Potential Molecular Druggable Target 92
Absence of Spred1, a negative regulator of Ras/MAPK pathway, as a mechanism responsible for the constitutive activation of RTK mediated signalling in acute leukemias 91
ROLE OF HAUSP/PTEN NETWORK IN CHRONIC LYMPHOID LEUKEMIA PATHOGENESIS AND THERAPY 90
MORGANA/CHP1 ACTS AS AN ONCOSUPPRESSOR IN CHRONIC MYELOID LEUKEMIA 90
HHV8-positive, HIV-negative multicentric Castleman’s disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma 89
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub 89
INHIBITION OF USP7 INDUCES GROWTH ARREST AND APOPTOSIS VIA PTEN IN CLL CELLS 88
Over-Expression of the P65 Subunit of NF-kB and Increased DNA Binding Activity of NF-kB Is a Common Event Both in Philadelphia Positive and Negative Chronic Myeloproliferative Disorders. 88
The NF-kappaB pathway blockade by the IKK inhibitor PS1145 can overcome Imatinib resistance 87
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 87
HAUSP compartmentalization in chronic myeloid leukemia 86
Bone marrow granulomatosis: Two case reports 85
BCR-ABL inactivates cytosolic PTEN through casein kinase II mediated tail phosphorylation. 83
Future perspectives from lung cancer pre-clinical models: new treatments are coming? 82
Blocking Extracellular Chaperones to Improve Cardiac Regeneration 81
Therapeutic inhibition of HAUSP-PTEN network in chronic lymphocytic leukemia 79
WT-1 expression in childhood acute leukemias 79
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia. 77
NON GENOMIC LOSS OF FUNCTION OF TUMOR SUPPRESSORS IN CML: BCR-ABL PROMOTES P53 NUCLEAR EXCLUSION THROUGH THE INTERACTION WITH IKB-ALPHA 76
Non-Coding RNAs: The "Dark Side Matter" of the CLL Universe 76
FOXO3 TRANSCRIPTION FACTOR IS DELOCALIZED AND INACTIVATED IN ACUTE MYELOID LEUKEMIA PATIENTS 75
Morgana haploinsufficiency induces a myeloproliferative disorder like-chronic myeloid leukemia in mice. 74
Nuclear-cytoplasmic Shuttling in Chronic Myeloid Leukemia: Implications in Leukemia Maintenance and Therapy 74
CD7/CD56-positive acute myeloid leukemias are characterized by constitutive phosphorylation of the NF-kB subunit p65 at Ser536 73
La biologia molecolare delle sindromi mielodisplastiche 72
The synergism between DHODH inhibitors and dipyridamole leads to metabolic lethality in acute myeloid leukemia 71
The challenge of hemorrhagic shock management during low-molecular-weight heparin treatment 69
Activation of NF-kappaB is essential for hepatocyte growth factor-mediated proliferation and tubulogenesis. 68
Kinase-inhibitor–insensitive cancer stem cells in chronic myeloid leukemia 68
Bcr-Abl p210 delocalizes PTEN through a PML/HAUSP network 68
Activation of NF-kB is essential for HGF-mediated tubuligenesis, but not for protection from apoptosis 67
The Challenging Diagnosis of Pancreatic Masses: Not All Tumors Are Cancers 67
NF-kB inhibition as a strategy to enhance etoposide-induced apoptosis in K562 cell line 65
Update on emerging treatments for chronic myeloid leukemia 65
IκB-α: At the crossroad between oncogenic and tumor-suppressive signals 65
RUOLO DI PML E PTEN NELLA PATOGENESI DELLA LEUCEMIA MIELOIDE CRONICA 64
New perspectives for molecular targeted therapy in human leukemias 64
Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia 64
PCSK9 Biology and Its Role in Atherothrombosis 64
Transferrin Saturation Inversely Correlates with Platelet Function 62
Wilms’ tumour gene (WT1) is modulated by NF-kB transcriptional factor 60
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study 60
CD7/CD56-positive acute myeloid leukemias are characterized by constitutive phosphorylation of the NF-kB subunit p65 at Ser536. 59
The Role of PTEN in Myeloid Malignancies 58
Unleashing the Guardian: The Targetable BCR-ABL/HAUSP/PML/PTEN Network in Chronic Myeloid Leukemia 57
Transferrin Saturation and Its Association with Platelet Reactivity 57
Valproate enhances imatinib-induced growth arrest and apoptosis in chronic myeloid leucemia cells 56
FOXO TRANSCRIPTION FACTOR IS DELOCALIZED AND INACTIVATED IN CML PATIENTS BY BCR-ABL ONCOGENIC SIGNALLING 56
Overexpression of the p65 subunit of NF-KB and IKB mediated nuclear sequestration of p53 as common events in Philadelphia positive and negative myeloproliferative disorders 55
Overexpression of the p65 subunit of NF-KB and IKB mediated nuclear sequestration of p53 as common events in Philadelphia positive and negative Chronic Myeloid Leukemia 55
Totale 11.093
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.306
article - articoli 0
book - libri 0
conference - conferenze 13.367
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.673
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.240 0 0 0 0 0 312 209 159 189 159 101 111
2020/20211.690 132 105 156 57 135 143 154 75 153 162 146 272
2021/20221.705 126 62 56 155 76 94 119 86 55 198 357 321
2022/20232.102 227 169 36 179 176 598 176 116 207 37 116 65
2023/20241.073 114 152 49 68 71 176 42 59 18 63 95 166
2024/20251.650 50 234 141 280 764 181 0 0 0 0 0 0
Totale 13.469